These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36718920)

  • 1. Development of an apolipoprotein E mimetic peptide-lipid conjugate for efficient brain delivery of liposomes.
    Kato N; Yamada S; Suzuki R; Iida Y; Matsumoto M; Fumoto S; Arima H; Mukai H; Kawakami S
    Drug Deliv; 2023 Dec; 30(1):2173333. PubMed ID: 36718920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of High-Functionality and -Quality Lipids with RGD Peptide Ligands: Application for PEGylated Liposomes and Analysis of Intratumoral Distribution in a Murine Colon Cancer Model.
    Suga T; Kato N; Hagimori M; Fuchigami Y; Kuroda N; Kodama Y; Sasaki H; Kawakami S
    Mol Pharm; 2018 Oct; 15(10):4481-4490. PubMed ID: 30179010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand peptide-grafted PEGylated liposomes using HER2 targeted peptide-lipid derivatives for targeted delivery in breast cancer cells: The effect of serine-glycine repeated peptides as a spacer.
    Suga T; Fuchigami Y; Hagimori M; Kawakami S
    Int J Pharm; 2017 Apr; 521(1-2):361-364. PubMed ID: 28237886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of High Functionality and Quality Cell-penetrating Peptide Conjugated Lipid for Octaarginine Modified PEGylated Liposomes In U251 and U87 Glioma Cells.
    El-Gamal FR; Akl MA; Mowafy HA; Mukai H; Kawakami S; Afouna MI
    J Pharm Sci; 2022 Jun; 111(6):1719-1727. PubMed ID: 34863974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting.
    Du Q; Liu Y; Fan M; Wei S; Ismail M; Zheng M
    J Control Release; 2024 Aug; 372():85-94. PubMed ID: 38838784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain.
    Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
    J Pharmacol Exp Ther; 2020 Sep; 374(3):354-365. PubMed ID: 32561686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.
    Kang YS; Jung HJ; Oh JS; Song DY
    CNS Neurosci Ther; 2016 Oct; 22(10):817-23. PubMed ID: 27350533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries.
    Hülsermann U; Hoffmann MM; Massing U; Fricker G
    J Drug Target; 2009 Sep; 17(8):610-8. PubMed ID: 19694613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of glutathione conjugation on the transcellular transport process of PEGylated liposomes across the blood brain barrier.
    Reginald-Opara JN; Tang M; Svirskis D; Chamley L; Wu Z
    Int J Pharm; 2022 Oct; 626():122152. PubMed ID: 36055442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting.
    Xie F; Yao N; Qin Y; Zhang Q; Chen H; Yuan M; Tang J; Li X; Fan W; Zhang Q; Wu Y; Hai L; He Q
    Int J Nanomedicine; 2012; 7():163-75. PubMed ID: 22275832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: Application of cyclic RGD peptide.
    Kato N; Sato T; Fuchigami Y; Suga T; Geng L; Tsurumaru M; Hagimori M; Mukai H; Kawakami S
    Eur J Pharm Sci; 2022 Sep; 176():106239. PubMed ID: 35714942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system.
    Wang Z; Zhao Y; Jiang Y; Lv W; Wu L; Wang B; Lv L; Xu Q; Xin H
    Sci Rep; 2015 Jul; 5():12651. PubMed ID: 26219474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Sensitive PEGylated liposomes functionalized with a fibronectin-mimetic peptide show enhanced intracellular delivery to colon cancer cell.
    Garg A; Kokkoli E
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1135-43. PubMed ID: 21470144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
    Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
    Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
    Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
    ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.
    Rotman M; Welling MM; Bunschoten A; de Backer ME; Rip J; Nabuurs RJ; Gaillard PJ; van Buchem MA; van der Maarel SM; van der Weerd L
    J Control Release; 2015 Apr; 203():40-50. PubMed ID: 25668771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic Post-Insertion Method for the Efficient Preparation of PEGylated Liposomes Using High Functionality and Quality Lipids.
    Sugimoto Y; Suga T; Kato N; Umino M; Yamayoshi A; Mukai H; Kawakami S
    Int J Nanomedicine; 2022; 17():6675-6686. PubMed ID: 36597433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.
    Garg A; Tisdale AW; Haidari E; Kokkoli E
    Int J Pharm; 2009 Jan; 366(1-2):201-10. PubMed ID: 18835580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.